WEINHEIM, Germany—Despite its relative scientific youth, nanotechnology has been touted far and wide for the impact it will have on every facet of life. As proof of its growth in the biomedical fields, Wiley-VCH Verlag GmbH recently published Biological and Pharmaceutical Nanomaterials (ISBN: 3-527-31382-6). Edited by Dr. Challa Kumar, group leader of nanofabrication at LSU's Center for Advanced Microstructure Devices, the book is the second in Wiley's Nanotechnologies for the Life Sciences series.
Continue reading below...
WebinarsAccelerating rare disease clinical trials
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
Read MoreThe book tries to walk the ever-challenging tightrope of providing quick but detailed surveys of the nanoparticle world, describing everything from DNA nanotubes to lipoplexes to protein nanoparticles. The materials scientists in the audience will enjoy the first two sections of the book, which are rife with details about the construction of different particles. For the biomolecular researchers, however, these sections are practically devoid of information as to why any of this matters to people trying to diagnose disease or formulate new drug delivery platforms.
